![PDF) Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome PDF) Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome](https://i1.rgstatic.net/publication/342607865_Validation_of_the_four-miRNA_biomarker_panel_MiCaP_for_prediction_of_long-term_prostate_cancer_outcome/links/5efcc862a6fdcc4ca440d581/largepreview.png)
PDF) Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome
![IJMS | Free Full-Text | Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer | HTML IJMS | Free Full-Text | Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer | HTML](https://www.mdpi.com/ijms/ijms-20-01173/article_deploy/html/images/ijms-20-01173-g005.png)
IJMS | Free Full-Text | Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer | HTML
![Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome | Scientific Reports Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-67320-y/MediaObjects/41598_2020_67320_Fig1_HTML.png)